Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Potential of PARP inhibitors for metastatic breast cancer

Dr Alexandra Zimmer - National Cancer Institute, Bethesda, USA
Potential of PARP inhibitors for metastatic breast cancer ( Dr Alexandra Zimmer - National Cancer Institute, Bethesda, USA )
3 Jun 2019

New agent targeting Nectin-4 produces responses in nearly half of patients with advanced urothelial cancer

Prof Daniel Petrylak - Yale Cancer Center, New Haven, USA
New agent targeting Nectin-4 produces responses in nearly half of patients with advanced urothelial cancer ( Prof Daniel Petrylak - Yale Cancer Center, New Haven, USA )
3 Jun 2019

No difference in survival between laparoscopic surgery and open surgery in colorectal cancer patients with liver metastases

Dr Åsmund Fretland - Oslo University Hospital, Oslo, Norway
No difference in survival between laparoscopic surgery and open surgery in colorectal cancer patients with liver metastases ( Dr Åsmund Fretland - Oslo University Hospital, Oslo, Norway )
3 Jun 2019

PARP inhibitor olaparib as treatment for pancreatic cancer patients with BRCA gene mutations

Dr Hedy Kindler - University of Chicago, Chicago, USA
PARP inhibitor olaparib as treatment for pancreatic cancer patients with BRCA gene mutations ( Dr Hedy Kindler - University of Chicago, Chicago, USA )
2 Jun 2019

Biomarker analysis from JAVELIN Renal 101: Avelumab plus axitinib versus sunitinib in aRCC

Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
Biomarker analysis from JAVELIN Renal 101: Avelumab plus axitinib versus sunitinib in aRCC ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
1 Jun 2019

KEYNOTE-001: Five year data from the phase Ib trial studying pembrolizumab as treatment for aNSCLC

Dr Edward B. Garon - UCLA, Los Angeles, USA
KEYNOTE-001: Five year data from the phase Ib trial studying pembrolizumab as treatment for aNSCLC ( Dr Edward B. Garon - UCLA, Los Angeles, USA )
1 Jun 2019

Ovarian cancer: Current treatments and latest advances

Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK
Ovarian cancer: Current treatments and latest advances ( Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK )
24 May 2019

Latest in ovarian cancer treatment

Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK
Latest in ovarian cancer treatment ( Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK )
24 May 2019

Artificial intelligence and treatment decisions

Dr Pratik Shah - Massachusetts Institute of Technology, Cambridge, USA
Artificial intelligence and treatment decisions ( Dr Pratik Shah - Massachusetts Institute of Technology, Cambridge, USA )
24 May 2019

MLL-rearranged acute lymphoblastic leukaemia

Dr Pablo Menéndez - Josep Carreras Leukemia Research Institute, Barcelona, Spain
MLL-rearranged acute lymphoblastic leukaemia ( Dr Pablo Menéndez - Josep Carreras Leukemia Research Institute, Barcelona, Spain )
24 May 2019

Epigenetic expression in T cell leukaemia

Dr Sinisa Dovat - Penn State Cancer Institute, Hershey, USA
Epigenetic expression in T cell leukaemia ( Dr Sinisa Dovat - Penn State Cancer Institute, Hershey, USA )
24 May 2019

Managing metabolism and drug toxicity in acute lymphoblastic leukaemia

Dr Mary Relling - St Jude's Children's Research Hospital, Memphis, USA
Managing metabolism and drug toxicity in acute lymphoblastic leukaemia ( Dr Mary Relling - St Jude's Children's Research Hospital, Memphis, USA )
24 May 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation